| Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status. | |
| | |
MedLine Citation:
|
PMID: 19441129 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Using a structured interview method, we sought to address the following questions regarding cervical dystonia (CD) and employment: (1) what is the frequency and severity of job impairment in CD; (2) what are the clinical features that contribute to job impairment; (3) how does the effectiveness of botulinum toxin (BTx) compare to oral medications in restoring employment status. In our population of 155 CD patients, employment was affected by CD in 53.3% (31.2% reduced hours or responsibilities, 3.3% changed to different job, 18.9% loss of employment) and 68.9% of patients reported reduced overall productivity. The likelihood of altered employment (P < 0.0006), reduced productivity (P < 0.0001), and seeking disability benefits (P < 0.003) was significantly associated with the presence of neck pain, but not type of employment, spasmodic head motions, or duration of CD symptoms before treatment with BTx. Treatment with BTx was more likely to improve employment status than oral medications (66.1 vs. 18.5%) and much more likely to restore full employment with normal productivity (12.9 vs. 0.0%). These findings suggest that employment status is frequently affected by CD, particularly in patients withneck pain. BTx is significantly more effective than oral medications in restoring premorbid employment status. |
| | |
Authors:
|
Eric S Molho; Nitendra Agarwal; Katy Regan; Donald S Higgins; Stewart A Factor |
Related Documents
:
|
20685159 - Comparing the working time between bar-code medication administration system and tradit... 11553109 - Accuracy of diagnoses of hiv-related oral lesions by medical clinicians. findings from ... 20431159 - Oral health in children guidelines for pediatricians. 2197099 - Metamizole: reassessment of its therapeutic role. 6643209 - Apparent oral contraceptive failure associated with antibiotic administration. 19486709 - Helping women choose appropriate hormonal contraception: update on risks, benefits, and... 801639 - Religion and reality: the three doubts of hillel. 332299 - Autopsy of an egyptian mummy (nakht--rom i). 15383379 - Investigating the use of negatively phrased survey items in medical education settings:... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Movement disorders : official journal of the Movement Disorder Society Volume: 24 ISSN: 1531-8257 ISO Abbreviation: Mov. Disord. Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2009-08-03 Completed Date: 2009-10-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8610688 Medline TA: Mov Disord Country: United States |
Other Details:
|
Languages: eng Pagination: 1384-7 Citation Subset: IM |
Copyright Information:
|
2009 Movement Disorder Society. |
Affiliation:
|
Neurosciences Institute, Albany Medical Center, NY 12208, USA. molhoe@mail.amc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Dyskinesia Agents
/
therapeutic use Botulinum Toxins / therapeutic use Disability Evaluation Employment* Female Humans Male Middle Aged Pain Measurement Retrospective Studies Torticollis / drug therapy, economics*, epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Dyskinesia Agents; 0/Botulinum Toxins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Walking economy in people with Parkinson's disease.
Next Document: Cross-sectional and longitudinal studies of three-dimensional stereotactic surface projection SPECT ...